Plus Therapeutics (PSTV) Amortizatization of Intangibles (2015 - 2026)
Plus Therapeutics (PSTV) reported Amortizatization of Intangibles of $13000.0 for Q1 2026, down 62.86% year-over-year from $35000.0 in Q1 2025, and up 129.55% quarter-over-quarter from -$44000.0 in Q4 2025.
Plus Therapeutics (PSTV) Amortizatization of Intangibles (2015 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has 7 years of Amortizatization of Intangibles data on file, last reported at $13000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $13000.0, down 62.86% year-over-year; the trailing twelve-month figure through Mar 2026 was -$13000.0 (down 111.3% YoY), and the FY2025 annual result was $9000.0, down 91.89% from the prior year.
- Amortizatization of Intangibles improved to $13000.0 in Q1 2026 per PSTV's latest filing, from -$44000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $47000.0 in Q3 2024 and troughed at -$44000.0 in Q4 2025.
- A 5-year average of $20176.5 and a median of $28000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- On a YoY basis, Amortizatization of Intangibles climbed as much as 212.5% in 2025 and fell as far as 207.32% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $27000.0 in 2022, then gained by 14.81% to $31000.0 in 2023, then jumped by 32.26% to $41000.0 in 2024, then slumped by 207.32% to -$44000.0 in 2025, then soared by 129.55% to $13000.0 in 2026.
- Business Quant data shows PSTV's Amortizatization of Intangibles at $13000.0 in Q1 2026, -$44000.0 in Q4 2025, and $9000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Plus Therapeutics | 35.99 Mn | 20.87 Mn | - | 13,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,000.00 |
| Mar 31, 2026 | 13,000.00 |
| Dec 31, 2025 | -44,000.00 |
| Dec 31, 2025 | -44,000.00 |
| Sep 30, 2025 | 9,000.00 |
| Sep 30, 2025 | 9,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Sep 30, 2024 | 47,000.00 |
| Sep 30, 2024 | 47,000.00 |
| Jun 30, 2024 | -8,000.00 |
| Jun 30, 2024 | -8,000.00 |
| Mar 31, 2024 | 31,000.00 |
| Mar 31, 2024 | 31,000.00 |
| Dec 31, 2023 | 31,000.00 |
| Dec 31, 2023 | 31,000.00 |